Chugai Pharmaceutical : Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
April 22, 2021 at 03:32 am
Share
April 22, 2021
Name of listed company: Chugai Pharmaceutical Co., Ltd.
Code number:
4519 (1st Section of Tokyo Stock Exchange)
Head office:
1-1,Nihonbashi-Muromachi2-Chome,Chuo-ku, Tokyo
President & CEO:
Osamu Okuda
Inquiries to:
Toshiya Sasai
Head of Corporate Communications Dept.
Tel: +81-(0)3-3273-0554
Notice of Completion of Disposal of Treasury Shares as Restricted
Stock Compensation Plan
TOKYO, April 22, 2021--Chugai Pharmaceutical Co., Ltd.announced that disposal of treasury shares was completed today, as we announced in the press release "Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan" on March 23, 2021. The result of treasury shares is as follows.
1. Overview of Disposal
(1)
Disposal date
April 22, 2021
(2)
Class and number of disposed shares
96,600 shares of Common stock of the Company
(3)
Disposal price
¥4,456 per share
(4)
Total value of disposed shares
¥430,449,600
(5)
Allottees and number thereof;
Directors
3
59,300 shares
number of disposed shares
Vice presidents
14
15,100 shares
Employees
106
22,200 shares
###
Attachments
Original document
Permalink
Disclaimer
Chugai Pharmaceutical Co. Ltd. published this content on 22 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 April 2021 02:31:05 UTC.
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).